Enlivex Therapeutics Ltd.

About Enlivex Therapeutics Ltd.

Enlivex is a biotechnology company focused on harnessing the natural healing power of macrophages to treat inflammatory diseases through their proprietary off-the-shelf cell therapy platform, Allocetra™. Their mission is to redefine the treatment of inflammatory diseases with novel therapeutic mechanisms.

Products & Services

Allocetra™:An off-the-shelf cell therapy platform with flexible administration options, including systemic intravenous infusion or targeted local injections. It has been safely tested on over 150 patients with no reported serious adverse events and is being evaluated for acute and chronic inflammatory diseases such as sepsis and osteoarthritis.

Allocetra™

Specialties

Cell Therapy Treatment of Inflammatory Diseases Macrophage-based Therapies Sepsis Treatment Osteoarthritis Treatment Macrophage reprogramming therapy Prediction markets treasury

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 212000000 MR: - FA: 212,000,000 FAN: 212000000	D: 2025-11-26 FD: 2025-11-26	-
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 5000000 MR: - FA: approximately $5.0 million FAN: 5000000	D: 2024-05-29 FD: 2024-05-29	1 investors
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 5000000 MR: - FA: approximately $5.0 million FAN: 5000000	D: 2024-05-28 FD: 2024-05-28	1 investors

Private Placement Latest

2025-11-26

$212.0M

Registered Direct Offering 2024-05-29

$5.0M

Registered Direct Offering 2024-05-28

$5.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News